DekaBank Deutsche Girozentrale’s Minerva Neurosciences NERV Stock Holding History

DekaBank Deutsche Girozentrale’s Portfolio NERV Stock Details NERV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-4,063	Closed	-$266K	–	1186
2019 Q3	$266K	Sell	4,063 -4,062	-50%	-$230K	﹤0.01%	823
2019 Q2	$355K	Buy	+8,125	New	+$407K	﹤0.01%	959
2019 Q1	–	Sell	-4,063	Closed	-$210K	–	1241
2018 Q4	$210K	Buy	+4,063	New	+$297K	﹤0.01%	961

Other funds holding NERV

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

IVAI

Index Venture Associates IV St. Helier, Channel Islands, Jersey $6.24M AUM

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

SFM

Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return

DekaBank Deutsche Girozentrale's NERV Position: Q4 2019 in Review

DekaBank Deutsche Girozentrale sold out of Minerva Neurosciences (NERV) in Q4 2019, closing a stake of 4,063 shares — an estimated $266K sold.

DekaBank Deutsche Girozentrale first reported a position in NERV in Q4 2018 and held it in 3 quarters. The position peaked at $355K in Q2 2019. 92 funds tracked by Wall St. Rank hold NERV as of Q4 2019.

DekaBank Deutsche Girozentrale reported no remaining Minerva Neurosciences position as of Q4 2019 after selling out during the quarter.
DekaBank Deutsche Girozentrale sold 4,063 Minerva Neurosciences shares in Q4 2019, an estimated $266K.
DekaBank Deutsche Girozentrale first reported a position in Minerva Neurosciences in Q4 2018 and held it in 3 quarters.
DekaBank Deutsche Girozentrale's Minerva Neurosciences position peaked at $355K in Q2 2019.
92 funds tracked by Wall St. Rank held Minerva Neurosciences as of Q4 2019.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q4 2019, filed 4 Feb 2020.